glp-1 and macular degeneration Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists decrease retinal GLP-1s for Weight Loss May
Description
and Novo Nordisk A/S were sued Wednesday by a top compounding pharmacy that makes copycat versions of their blockbuster obesity and diabetes drugs.
Senior Litigation Counsel Jason Goldstein of Parker Waichman LLP appointed Co-Chair of the Plaintiffs Executive Committee in MDL 3163.
What concerns me most is the amount of misinformation being spread by individuals who have never prescribed these medications, never followed patients longitudinally, and often rely on fear rather than evidence
The 'Insurance Skip' play
What does evidence say about GLP-1 agonists and suicidal ideation
REGULATE DIGESTION
